-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WxNtfO0akwXYB1DDZ0rjIpK46azAOqYBczf7uOLhw59fURY2NjfK4hOXlXy8AyB/ dfyvPrf9CJtu3EpS+PRICw== 0000874015-10-000021.txt : 20100721 0000874015-10-000021.hdr.sgml : 20100721 20100721200107 ACCESSION NUMBER: 0000874015-10-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100719 FILED AS OF DATE: 20100721 DATE AS OF CHANGE: 20100721 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROOKE STANLEY T CENTRAL INDEX KEY: 0000897667 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 10963258 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-07-19 0000874015 ISIS PHARMACEUTICALS INC ISIS 0000897667 CROOKE STANLEY T C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD CA 92008 1 1 0 0 Chairman, President, CEO Employee Stock Option (right to buy) 9.22 2010-07-19 2010-07-19 4 A 0 18750 0 A 2011-07-19 2017-07-18 Common Stock 18750 18750 I By wife Grant of 7-19-10 to reporting person's wife of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan in connection with her promotion. 25% of the shares subject to the option will vest and become exercisable on 7-19-11. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 4,688 shares per year. The option is exercisable as to 0 shares on 7-19-10. /s/B. Lynne Parshall, Attorney-in-Fact 2010-07-21 -----END PRIVACY-ENHANCED MESSAGE-----